352 related articles for article (PubMed ID: 26354995)
21. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity.
Zhang Y; El-Sikhry H; Chaudhary KR; Batchu SN; Shayeganpour A; Jukar TO; Bradbury JA; Graves JP; DeGraff LM; Myers P; Rouse DC; Foley J; Nyska A; Zeldin DC; Seubert JM
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H37-46. PubMed ID: 19429816
[TBL] [Abstract][Full Text] [Related]
23. Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice.
Grant MK; Seelig DM; Sharkey LC; Zordoky BN
Biol Sex Differ; 2017; 8():1. PubMed ID: 28078076
[TBL] [Abstract][Full Text] [Related]
24. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
25. Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3'-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis.
Hajra S; Basu A; Singha Roy S; Patra AR; Bhattacharya S
Free Radic Res; 2017 Oct; 51(9-10):812-827. PubMed ID: 28922986
[TBL] [Abstract][Full Text] [Related]
26. VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection.
Räsänen M; Degerman J; Nissinen TA; Miinalainen I; Kerkelä R; Siltanen A; Backman JT; Mervaala E; Hulmi JJ; Kivelä R; Alitalo K
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13144-13149. PubMed ID: 27799559
[TBL] [Abstract][Full Text] [Related]
27. Prevention of doxorubicin (DOX)-induced genotoxicity and cardiotoxicity: Effect of plant derived small molecule indole-3-carbinol (I3C) on oxidative stress and inflammation.
Hajra S; Patra AR; Basu A; Bhattacharya S
Biomed Pharmacother; 2018 May; 101():228-243. PubMed ID: 29494960
[TBL] [Abstract][Full Text] [Related]
28. Candidate early predictive plasma protein markers of doxorubicin-induced chronic cardiotoxicity in B6C3F
Desai VG; Lee T; Moland CL; Vijay V; Han T; Lewis SM; Herman EH; Fuscoe JC
Toxicol Appl Pharmacol; 2019 Jan; 363():164-173. PubMed ID: 30517846
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway.
Kim KH; Oudit GY; Backx PH
J Pharmacol Exp Ther; 2008 Jan; 324(1):160-9. PubMed ID: 17928571
[TBL] [Abstract][Full Text] [Related]
30. Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity.
Legi A; Rodriguez E; Eckols TK; Mistry C; Robinson P
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917491
[No Abstract] [Full Text] [Related]
31. Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin.
Neilan TG; Blake SL; Ichinose F; Raher MJ; Buys ES; Jassal DS; Furutani E; Perez-Sanz TM; Graveline A; Janssens SP; Picard MH; Scherrer-Crosbie M; Bloch KD
Circulation; 2007 Jul; 116(5):506-14. PubMed ID: 17638931
[TBL] [Abstract][Full Text] [Related]
32. CYP1B1 inhibition attenuates doxorubicin-induced cardiotoxicity through a mid-chain HETEs-dependent mechanism.
Maayah ZH; Althurwi HN; Abdelhamid G; Lesyk G; Jurasz P; El-Kadi AO
Pharmacol Res; 2016 Mar; 105():28-43. PubMed ID: 26772815
[TBL] [Abstract][Full Text] [Related]
33. Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicity.
Gioffré S; Ricci V; Vavassori C; Ruggeri C; Chiesa M; Alfieri I; Zorzan S; Buzzetti M; Milano G; Scopece A; Castiglioni L; Sironi L; Pompilio G; Colombo GI; D'Alessandra Y
Biomed Pharmacother; 2019 Feb; 110():1-8. PubMed ID: 30453253
[TBL] [Abstract][Full Text] [Related]
34. Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin- and trastuzumab-mediated cardiomyopathy.
Zeglinski M; Premecz S; Lerner J; Wtorek P; Dasilva M; Hasanally D; Chaudhary R; Sharma A; Thliveris J; Ravandi A; Singal PK; Jassal DS
Can J Cardiol; 2014 Mar; 30(3):359-67. PubMed ID: 24484915
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ
Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267
[No Abstract] [Full Text] [Related]
36. Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice.
Abdelgawad IY; George B; Grant MKO; Huang Y; Shan Y; Huang RS; Zordoky BN
Arch Toxicol; 2024 Apr; 98(4):1191-1208. PubMed ID: 38244039
[TBL] [Abstract][Full Text] [Related]
37. A herbal formula, SYKT, reverses doxorubicin‑induced myelosuppression and cardiotoxicity by inhibiting ROS‑mediated apoptosis.
Chen T; Shen HM; Deng ZY; Yang ZZ; Zhao RL; Wang L; Feng ZP; Liu C; Li WH; Liu ZJ
Mol Med Rep; 2017 Apr; 15(4):2057-2066. PubMed ID: 28260045
[TBL] [Abstract][Full Text] [Related]
38. Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy-Induced Cardiotoxicity.
Naresh NK; Misener S; Zhang Z; Yang C; Ruh A; Bertolino N; Epstein FH; Collins JD; Markl M; Procissi D; Carr JC; Allen BA
NMR Biomed; 2020 Sep; 33(9):e4327. PubMed ID: 32567177
[TBL] [Abstract][Full Text] [Related]
39. Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis.
Hao E; Mukhopadhyay P; Cao Z; Erdélyi K; Holovac E; Liaudet L; Lee WS; Haskó G; Mechoulam R; Pacher P
Mol Med; 2015 Jan; 21(1):38-45. PubMed ID: 25569804
[TBL] [Abstract][Full Text] [Related]
40. Early metabolomics changes in heart and plasma during chronic doxorubicin treatment in B6C3F1 mice.
Schnackenberg LK; Pence L; Vijay V; Moland CL; George N; Cao Z; Yu LR; Fuscoe JC; Beger RD; Desai VG
J Appl Toxicol; 2016 Nov; 36(11):1486-95. PubMed ID: 26934058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
